Annona muricata leaves induce G cell cycle arrest and apoptosis
through mitochondria-mediated pathway in human HCT-116 and
HT-29 colon cancer cells I.
II.
III.
IV.
V.
VI.
Product / Ingredient Studied
a. Annona muricata L. (Annona muricata) as a member of the Annonaceae family, the custard apple family, is a small tropical tree widely cultivated throughout the tropical countries. Annona species such as Annona squamosa and Annona reticulata are well known to have traditional application in the tropics b. The popular fruit tree of Annona muricata known also as graviola or soursop has extensive ethnobotonical uses, such as sedative, astringent,piscicide,insecticide,vermifuge,hypotensive,antiparasiticand antispasmodic. c. Furthermore, it is traditionally used for the treatment of fevers, asthma, pain, coughs, wound and skin remedies d. Annona muricata was described as the cancer killer due to its remarkable cytotoxicity against various cancer cell lines. The seeds and leaves of Annona muricata have been widely used by the natives in South America for the treatment of cancer and tumors. Indication a. To establish the possible apoptotic pathways induced in HT-29 and HCT-116 colon cancer cells by ethyl acetate extract of Annona muricata leaves. Type of Claim a. The stems, barks and leaves of Annona muricata revealed noteworthy antiproliferative effects against cancer cells without affecting normal cells Dosage and Administration a. The antiproliferative potential of the three isolated extracts was expressed as IC50 value, the concentration of plant extract that caused 50% inhibition of cell growth which was calculated based on the percentage of cell viability. As ethyl acetate extract of Annona muricata leaves (EEAM) showed the strongest IC50, which was used to continue the study. Type of Study (Human or Animal) a. Human cells b. CD841 (normal human colon epithelial cells) c. HT-29 and HCT116 (human colon cancer cells) Study Design (Experimental or Observational) a. Experimental in vitro b. CCD841 (normal human colon epithelial cells), HT-29 and HCT116 (human colon cancer cells) were obtained from the American Type Cell Collection (ATCC, Manassas, VA, USA). The cells were maintained in RPMI-1640 medium (Sigma, St. Louis, MO, USA) supplemented with
Lab) and 100 U/ml penicillin (PAA Lab) in a humidied atmosphere with 5% CO in the air at 37 1C. Cells in the exponential growth phase were collected for the following experiments. The negative control for all the assays was represented by the untreated medium containing vehicle DMSO (0.1%). Study Population a. Colon cancer Duration of the Study a. Incubated for 72 h. Study End Points a. Cell viability was evaluated by using the 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium (MTT) assay. b. In brief, cells (5 x 10 4 cells/ml) were treated with three isolated extracts at different concentrations in 96-well plate and incubated for 72 h. Ethics Committee Approval a. Not mentioned within the article. Limitation of the Study a. Not stated within the article. Study Results a. EEAM exerted signicant cytotoxic effects on HCT-116 and HT-29 cells as determined by MTT and LDH assays. b. After 24 h treatment, EEAM exhibited the IC value of 11.4371.87 mg/ml and 8.9871.24 mg/ml against HT-29 and HCT-116 cells, respectively. Flow cytometric analysis demonstrated the cell cycle arrest at G1 50 phase and phosphatidylserine externalization conrming the induction of apoptosis. c. EEAM treatment caused excessive accumulation of ROS followed by disruption of MMP, cytochrome c leakage and activation of the initiator and executioner caspases in both colon cancer cells. Immunouorescence analysis depicted the up-regulation of Bax and down-regulation of Bcl-2 proteins while treated with EEAM. d. Furthermore, EEAM conspicuously blocked the migration and invasion of HT-29 and HCT-116 cells. Source of Evidence: a. Moghadamtousi, S.Z., et al., Annona muricata leaves induce G1 cell cycle arrest and apoptosis through mitochondria-mediated pathway in human.... Journal of Ethnopharmacology (2014), http://dx.doi.org/10.1016/j.jep.2014.08.011i